|
LIBERTY CORNER, N.J., Aug. 7 /PRNewswire/ -- GeneraMedix
Inc. has
received FDA approval; and has launched Carboplatin Injection,
Fluorouracil
Injection, USP, and Methotrexate Injection, USP.
GeneraMedix offers the following presentations: Carboplatin
Injection:
10 mg/mL; 5 mL, 15 mL and 45 mL vials, Fluorouracil Injection,
USP: 50
mg/mL; 10 mL, 20 mL, 50 mL and 100 mL vials and Methotrexate
Injection,
USP: 25 mg/mL; 2 mL, 10 mL and 40 mL vials, preservative
free.
These are the first products launched resulting from
a long term,
multi- product partnership between GeneraMedix Inc. and
Intas
Pharmaceuticals Ltd., a leading India based pharmaceutical
company. Under
the terms of the partnership, Intas developed the products
and provides the
commercial supplies.
Ronald F. Quadrel, President and CEO of GeneraMedix,
Inc. stated, "We
are very pleased to enter into this strategic relationship
with Intas
Pharmaceuticals as we continue to build our generic injectable
product
portfolio. The Intas agreement reinforces our long term
commitment to
provide a broad range of generic injectable products to
U.S. hospitals,
surgery centers and clinics."
Samir Mehta, Executive Vice President (USA) of Intas
Pharmaceuticals
Ltd said, "We are very pleased with this strategic
alliance, integrating
our product development and manufacturing capabilities
with the regulatory
affairs, marketing and distribution capabilities of GeneraMedix.
The launch
of these three products is the first step towards the realization
of this
strategy."
About Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals was founded in 1976, and has grown
to become one
of India's top twenty (20) pharmaceutical companies. Intas
specializes in
product development and manufacturing and has a presence
in more than
forty-two (42) countries around the world. Intas has a
state-of-the-art
cytotoxic manufacturing facility. The company received
FDA approval at its
Matoda, India facility in 2006. Additional information
is available at the
company's website at http://www.intaspharma.com.
About GeneraMedix Inc.
GeneraMedix Inc. is a privately held pharmaceutical company
offering
high quality generic injectable products to U.S. hospital
and specialty
markets. In addition to its products already marketed,
GeneraMedix has a
significant number of injectable products under development,
as well as a
number of products under FDA review. Headquartered in Liberty
Corner, New
Jersey, the company was founded in July, 2004. Additional
information is
available on the company's website at http://www.generamedix.com.
|
